{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:15:14Z","timestamp":1773746114480,"version":"3.50.1"},"reference-count":45,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2017,3,10]]},"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The present work aims to evaluate the presence of stromal tumour-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PDL1) expression in breast carcinomas and their correlation with available clinicopathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two independent series of invasive breast cancer (IBC), one including ductal carcinoma in situ (DCIS) pair-matched cases, were selected, and quantification of TILs was accomplished in each case. Immunohistochemistry was also performed to evaluate the expression of PDL1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In both cohorts evaluated, increased stromal TILs and PDL1 expression were present in about 10% of IBCs, being significantly associated with each other and both with grade 3 and triple-negative subtype. We observed a similar distribution of stromal TILs and PDL1 expression between DCIS and IBC. Finally, we observed that increased stromal TILs and PDL1 expression were significantly associated with cancer stem cell (CSC) markers, basal cell markers and vimentin expression. Interestingly, in IBC cases with vimentin expression, increased stromal TILs, as well as decreased PDL1 expression, disclosed a better clinical outcome, independently of the main classical BC prognostic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have confirmed the association of stromal TILs and PDL1 expression with aggressive forms of BC and that both are already found in in situ stages. We also showed that stromal TILs and PDL1 expression are associated with clinical outcome in cases enriched for a mesenchymal immunophenotype. We describe for the first time a close relationship between CSC markers and PDL1 expression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2016-203990","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:39:31Z","timestamp":1491251971000},"page":"860-867","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer"],"prefix":"10.1136","volume":"70","author":[{"given":"Ant\u00f3nio","family":"Pol\u00f3nia","sequence":"first","affiliation":[{"name":"Epithelial Interactions in Cancer (EPIC), i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"},{"name":"Department of Pathology, Ipatimup Diagnostics, Ipatimup, University of Porto, Porto, Portugal"},{"name":"FMUP, Faculty of Medicine, University of Porto, Porto, Portugal"}]},{"given":"Regina","family":"Pinto","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer (EPIC), i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"},{"name":"Department of Pathology, Ipatimup Diagnostics, Ipatimup, University of Porto, Porto, Portugal"}]},{"given":"Jorge F","family":"Cameselle-Teijeiro","sequence":"additional","affiliation":[{"name":"Complexo Hospitalar Universitario de Vigo (CHUVI), Vigo, Spain"}]},{"given":"Fernando C","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer (EPIC), i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"},{"name":"Department of Pathology, Ipatimup Diagnostics, Ipatimup, University of Porto, Porto, Portugal"},{"name":"FMUP, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Laboratoire National de Sant\u00e9, Dudelange, Luxembourg"}]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer (EPIC), i3S\u2014Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, Porto, Portugal"},{"name":"Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal"},{"name":"FMUP, Faculty of Medicine, University of Porto, Porto, Portugal"}]}],"member":"239","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"2025121220213756000_70.10.860.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21332"},{"key":"2025121220213756000_70.10.860.2","doi-asserted-by":"crossref","unstructured":"Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation. Cell 144:646\u201374. doi:10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2025121220213756000_70.10.860.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051424"},{"key":"2025121220213756000_70.10.860.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020177"},{"key":"2025121220213756000_70.10.860.5","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(92)90134-N"},{"key":"2025121220213756000_70.10.860.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02410.x"},{"key":"2025121220213756000_70.10.860.7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601400"},{"key":"2025121220213756000_70.10.860.8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601943"},{"key":"2025121220213756000_70.10.860.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1886"},{"key":"2025121220213756000_70.10.860.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.7370"},{"key":"2025121220213756000_70.10.860.11","doi-asserted-by":"crossref","unstructured":"Loi S , Sirtaine N , Piette F , et al . Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02\u201398. J Clin Oncol 2013;31:860\u20137. doi:10.1200\/JCO.2011.41.0902","DOI":"10.1200\/JCO.2011.41.0902"},{"key":"2025121220213756000_70.10.860.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.55.0491"},{"key":"2025121220213756000_70.10.860.13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu112"},{"key":"2025121220213756000_70.10.860.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4041"},{"key":"2025121220213756000_70.10.860.15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027"},{"key":"2025121220213756000_70.10.860.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm730"},{"key":"2025121220213756000_70.10.860.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099"},{"key":"2025121220213756000_70.10.860.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2005.09.007"},{"key":"2025121220213756000_70.10.860.19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/0008-5472.1089.65.3","article-title":"Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity","volume":"65","author":"Hirano","year":"2005","journal-title":"Cancer Res"},{"key":"2025121220213756000_70.10.860.20","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4591"},{"key":"2025121220213756000_70.10.860.21","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2011.090456"},{"key":"2025121220213756000_70.10.860.22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.humpath.2010.08.024","article-title":"Molecular phenotypes of matched in situ and invasive components of breast carcinomas","volume":"42","author":"Martins","year":"2011","journal-title":"Hum Pathol"},{"key":"2025121220213756000_70.10.860.23","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu450"},{"key":"2025121220213756000_70.10.860.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"2025121220213756000_70.10.860.25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/bjc.1996.438","article-title":"Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast","volume":"74","author":"Lee","year":"1996","journal-title":"Br J Cancer"},{"key":"2025121220213756000_70.10.860.26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2702"},{"key":"2025121220213756000_70.10.860.27","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3216"},{"key":"2025121220213756000_70.10.860.28","doi-asserted-by":"publisher","DOI":"10.1593\/neo.05733"},{"key":"2025121220213756000_70.10.860.29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22703"},{"key":"2025121220213756000_70.10.860.30","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-2988-5"},{"key":"2025121220213756000_70.10.860.31","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.634"},{"key":"2025121220213756000_70.10.860.32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu191"},{"key":"2025121220213756000_70.10.860.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.5037"},{"key":"2025121220213756000_70.10.860.34","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0987-8"},{"key":"2025121220213756000_70.10.860.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.9036"},{"key":"2025121220213756000_70.10.860.36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.05.9584"},{"key":"2025121220213756000_70.10.860.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1620-1"},{"key":"2025121220213756000_70.10.860.38","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0432-8"},{"key":"2025121220213756000_70.10.860.39","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.158"},{"key":"2025121220213756000_70.10.860.40","first-page":"963","article-title":"P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study","volume":"25","author":"Sousa","year":"2010","journal-title":"Histol Histopathol"},{"key":"2025121220213756000_70.10.860.41","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1075"},{"key":"2025121220213756000_70.10.860.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-005-0010-7"},{"key":"2025121220213756000_70.10.860.43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.18632\/oncotarget.1459","article-title":"P-cadherin signals through the laminin receptor alpha6beta4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells","volume":"5","author":"Vieira","year":"2014","journal-title":"Oncotarget"},{"key":"2025121220213756000_70.10.860.44","doi-asserted-by":"publisher","DOI":"10.1111\/his.12904"},{"key":"2025121220213756000_70.10.860.45","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4147"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2016-203990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:21:53Z","timestamp":1765599713000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2016-203990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,20]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/jclinpath-2016-203990"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2016-203990","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}